Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

2008372 citationsJournal Articlebronze Open Access

Authors

Oral lenalidomide monotherapy is active in relapsed or refractory aggressive NHL, with manageable side effects.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 26, Issue 30, pp. 4952-4957

Field-Weighted Citation Impact: 17.00